Literature DB >> 2193578

Metabolic responses to cachectin/TNF. A brief review.

K J Tracey1, A Cerami.   

Abstract

Cachectin/tumor necrosis factor (TNF-alpha) is a macrophage-secreted cytokine initially found to be a lipoprotein lipase-suppressing serum factor in cachectic, parasite-infected animals. Cloning of the cDNA encoding the gene for cachectin enabled biosynthesis of recombinant human cachectin and proof that the protein is identical to TNF-alpha. Numerous biological activities have subsequently been attributed to this pluripotent cytokine. In addition to suppressing LPL, cachectin/TNF mediates decreased lipogenic enzyme synthesis in adipocytes, causing a state of "cellular cachexia" in vitro. Similarly, catabolic cellular energy responses are induced by cachectin/TNF in cultured skeletal muscle cells which exhibit accelerated glycogenolysis, enhanced lactate production, and increased expression of hexose transporters. Persistent cachectin/TNF production occurs in chronic infection and malignancy, and chronic exposure induces a cachexia syndrome characterized by anorexia, weight loss, and anemia. Acute systemic appearance of cachectin/TNF is capable of inducing a state of lethal shock, disseminated hemorrhagic necrosis, catabolic hormone release, and multiple organ injury. Inhibiting the toxic effects of cachectin/TNF with monoclonal anti-cachectin antibodies during overwhelming Gram-negative bacteremia confers protection against septic shock. In these studies, the unprotected controls succumbed within hours, but baboons immunized against cachectin/TNF did not develop the characteristic increases of IL-1, IL-6, or catabolic stress hormones and did not die, suggesting that cachectin/TNF is a pivotal, proximal factor in the humoral cascade mediating septic shock syndrome. Recent evidence indicates that when produced in lesser quantities, cachectin/TNF may participate in the degradative and reparative mechanisms of physiological tissue remodelling and homeostasis. Future studies of the immunological and metabolic effects of cachectin/TNF should lead to a better understanding of the pathogenesis of infection and inflammation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2193578     DOI: 10.1111/j.1749-6632.1990.tb00173.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  26 in total

1.  Production and Purification of a Novel Anti-TNF-α Single Chain Fragment Variable Antibody.

Authors:  Ali Akbar Alizadeh; Maryam Hamzeh-Mivehroud; Siavoush Dastmalchi
Journal:  Adv Pharm Bull       Date:  2015-12-31

2.  Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.

Authors:  Fisun Karadag; Aslihan B Karul; Orhan Cildag; Mustafa Yilmaz; Hatice Ozcan
Journal:  Lung       Date:  2008-09-20       Impact factor: 2.584

3.  Frontiers in fiber nutrition: research and applications.

Authors:  Shiu-Ming Kuo; Christine L Pelkman
Journal:  Adv Nutr       Date:  2012-09-01       Impact factor: 8.701

Review 4.  Making a timely diagnosis of pulmonary tuberculosis.

Authors:  Richard Long
Journal:  Can Respir J       Date:  2015-10-15       Impact factor: 2.409

5.  Interaction of Bartonella henselae with the murine macrophage cell line J774: infection and proinflammatory response.

Authors:  T Musso; R Badolato; D Ravarino; S Stornello; P Panzanelli; C Merlino; D Savoia; R Cavallo; A N Ponzi; M Zucca
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

6.  Serum IL-10 and IL-6 levels at diagnosis as independent predictors of outcome in non-Hodgkin's lymphoma.

Authors:  M el-Far; M Fouda; R Yahya; H el-Baz
Journal:  J Physiol Biochem       Date:  2004-12       Impact factor: 4.158

7.  Soluble tumour necrosis factor receptors p55 and p75 in the urine monitor disease activity and the efficacy of treatment of inflammatory bowel disease.

Authors:  F Hadziselimovic; L R Emmons; H Gallati
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

8.  Maternal death following cardiopulmonary collapse after delivery: amniotic fluid embolism or septic shock due to intrauterine infection?

Authors:  Roberto Romero; Nicholas Kadar; Edi Vaisbuch; Sonia S Hassan
Journal:  Am J Reprod Immunol       Date:  2010-03-15       Impact factor: 3.886

9.  A biomarker panel to discriminate between systemic inflammatory response syndrome and sepsis and sepsis severity.

Authors:  Chamindie Punyadeera; E Marion Schneider; Dave Schaffer; Hsin-Yun Hsu; Thomas O Joos; Fabian Kriebel; Manfred Weiss; Wim Fj Verhaegh
Journal:  J Emerg Trauma Shock       Date:  2010-01

10.  Sequential changes in the cell mediators of peritoneal and wound fluids after surgery.

Authors:  A Tokunaga; M Onda; I Fujita; T Okuda; T Mizutani; T Kiyama; N Matsukura; T K Hunt
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.